gadolinium dtpa has been researched along with hoe 33342 in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (hoe 33342) | Trials (hoe 33342) | Recent Studies (post-2010) (hoe 33342) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 1,270 | 0 | 245 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, M; Dhubhghaill, SN; Farrar, GJ; Humphries, M; Humphries, P; Kenna, PF; Kiang, AS; Nguyen, AT; Tam, L | 1 |
1 other study(ies) available for gadolinium dtpa and hoe 33342
| Article | Year |
|---|---|
Reversible and size-selective opening of the inner Blood-Retina barrier: a novel therapeutic strategy.
Topics: Animals; Benzimidazoles; Blood-Retinal Barrier; Claudin-5; Cryoultramicrotomy; Extravasation of Diagnostic and Therapeutic Materials; Eye Diseases; Gadolinium DTPA; Injections; Magnetic Resonance Imaging; Membrane Proteins; Mice; Mice, Inbred C57BL; Molecular Weight; Perfusion; RNA Interference; RNA, Small Interfering | 2010 |